APOE and Alzheimer disease: Interestingly, previous studies [28] have shown type 2 CAA to be particularly common in early onset familial AD associated with PSEN-1 mutations, especially in those where the mutation is located after codon 200, in the absence of any APOE ε4 allele modifying effect.